Preview
Description
Esta ferramenta reproduz fielmente o modelo de impacto orçamental desenvolvido para a submissão do dossier de P&R e permite avaliar as consequências financeiras na RSS da introdução no mercado do ibrutinib em combinação com o venetoclax (I+V) para o tratamento de doentes adultos com leucemia linfocítica crónica (LLC) não tratada anteriormente (1L).
Technical Analysis
Package Overview Basic metadata
Bundle ID
com.seed.invictool.pt2 Current Version 1.0
Minimum iOS 12.0
Package Size App Store Size
Package Metadata 0 / 1 version records
Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.
Known Version Records
0 version records with stored package metadata • 1 known version records
Stored metadata does not guarantee a package is currently available to download.
| Details | Version / IDs | Version date | Action |
|---|---|---|---|
| Not archived | App Store ID: 874892670 | Unknown | Request Version |